Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1982-7-19
|
pubmed:abstractText |
We have studied the antileukemic effects of cyclosporin-A (CyA) on the cells of a number of human hematopoietic biopsies and established cell lines in vitro. Cya killed the tumor cells but not the nonmalignant control cells from three of four patients with T-lymphocytic leukemia/lymphoma at concentrations comparable to those recommended in clinical long-term immunosuppressive therapy. The leukemic cells from 7 patients with B-type chronic lymphocytic leukemia were insensitive to CyA. The drug was cytostatic and cytolytic to three of five T-lymphoblastic leukemia cell lines tested. With the possible exception of a plasma cell line, all other control cell lines (B-lymphocytic lymphoma, histiocytic lymphoma, fibroblast, and glia cell lines) were resistant to CyA. These observations indicate that CyA or its derivatives may be useful as a highly selective antitumor agent in different T-cell malignancies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1103-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6978740-B-Lymphocytes,
pubmed-meshheading:6978740-Cell Line,
pubmed-meshheading:6978740-Cyclosporins,
pubmed-meshheading:6978740-Humans,
pubmed-meshheading:6978740-Leukemia, Lymphoid,
pubmed-meshheading:6978740-Lymphoma,
pubmed-meshheading:6978740-Receptors, Antigen, B-Cell,
pubmed-meshheading:6978740-Rosette Formation,
pubmed-meshheading:6978740-T-Lymphocytes
|
pubmed:year |
1982
|
pubmed:articleTitle |
Cyclosporin-A is selectively cytotoxic to human leukemic T cells in vitro.
|
pubmed:publicationType |
Journal Article
|